About FDA

Office of Hematology Oncology Products (OHOP) Divisions and Programs

The Office of Hematology Oncology Drug Products (OHOP) is responsible for making safe and effective drugs for cancer available to the U.S. public. OHOP has the following components:

Page Last Updated: 10/15/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.